NEM
30
2
ROST
60
3
PWR
63
3
D
32
10
AAP
26
5
GWW
50
9
JNPR
59
3
T
32
2
GE
60
5
JBHT
46
4
MTB
38
4
CHD
34
7
OKE
61
2
MO
47
6
EOG
28
2
CNP
59
17
DLTR
52
8
NWS
69
5
PSX
24
2
EIX
61
8
NEM
30
2
ROST
60
3
PWR
63
3
D
32
10
AAP
26
5
GWW
50
9
JNPR
59
3
T
32
2
GE
60
5
JBHT
46
4
MTB
38
4
CHD
34
7
OKE
61
2
MO
47
6
EOG
28
2
CNP
59
17
DLTR
52
8
NWS
69
5
PSX
24
2
EIX
61
8
Financhill
Back

Halozyme Therapeutics Vs. Nukkleus Industry Stock Comparison

Buy
51

HALO
Halozyme Therapeutics

Last Price:
$46.95
Seasonality Move:
7.09%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Buy
51
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $46.93. The Score for HALO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $46.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.11 Sell
Relative Strength Index (14 RSI): 40.79 Sell
Chaikin Money Flow: -4132103 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.97 - 48.99) Sell
Bollinger Bands (100): (49.23 - 60.41) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.62 Sell
20-day SMA: 48.12 Sell
50-day SMA: 51 Sell
200-day SMA: 50.14 Sell
8-day EMA: 47.61 Sell
20-day EMA: 48.45 Sell
50-day EMA: 50.73 Sell
200-day EMA: 50.06 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):